Review date: June 10, 2026
Portfolio positioning
The Smart Manufacturing Portfolio is currently in its early build-out phase with one open position: ATS Corporation (ATS). ATS was added on June 9, 2026, and the stored quote history shows a first quote of $27.31 on June 8, 2026 and a latest quote of $27.54 on June 9, 2026, for a current return of 0.84%.
ATS remains a clean thematic fit for a factory automation portfolio. The company provides custom-designed, built, and installed manufacturing automation solutions to multinational customers across life sciences, food and beverage, transportation, consumer products, and energy. Its global operating footprint also fits the portfolio’s thematic mandate, which is not restricted to one regional exchange or country market. ([investors.atsautomation.com](https://investors.atsautomation.com/overview/default.aspx?utm_source=openai))
Recent performance drivers
The position is only one trading day old, so the early positive return should not be overinterpreted. The more important question is whether ATS still offers exposure to the long-term automation cycle: reshoring and regionalization of supply chains, labor scarcity, quality-control automation, regulated manufacturing, and the use of advanced robotics and machine vision in production environments.
ATS’s most recent fiscal fourth-quarter update showed mixed near-term conditions. Order bookings were C$704 million, down 18.4% year over year, while order backlog was C$1.958 billion at March 31, 2026, down 8.5% from the prior year. The trailing twelve-month book-to-bill ratio was 0.99:1, indicating that backlog conversion has been roughly in balance with new orders but not strongly expanding. ([businesswire.com](https://www.businesswire.com/news/home/20260528259819/en/ATS-Reports-Fourth-Quarter-Fiscal-2026-Results?utm_source=openai))
The key positive is that ATS still has a meaningful backlog and a diversified end-market base. Management continues to point to a strong and diversified life sciences funnel, including opportunities in pharmaceuticals, radiopharmaceuticals, medical devices, auto-injectors, wearable devices, pharmacy automation, contact lenses, and pre-filled syringes. These are attractive automation markets because customers often require precision, repeatability, regulatory compliance, and specialized production systems. ([businesswire.com](https://www.businesswire.com/news/home/20260528259819/en/ATS-Reports-Fourth-Quarter-Fiscal-2026-Results?utm_source=openai))
Risk concentration
The main portfolio risk today is not a stock-specific red flag but single-position concentration. With ATS as the only open holding, the portfolio’s near-term performance is fully dependent on one company’s order cycle, backlog execution, and investor sentiment toward industrial automation. That is acceptable during the launch phase, but it should not remain the long-term structure of a thematic portfolio.
For future additions, the portfolio should seek complementary exposure across the smart manufacturing stack: industrial robotics, machine vision, sensors, motion control, automation software, digital twins, programmable logic controllers, industrial AI, and precision manufacturing equipment. The goal should be to avoid overreliance on any single customer vertical, such as electric vehicles or life sciences, while preserving the portfolio’s core automation identity.
What to watch next
- Order bookings: The year-over-year decline in fiscal Q4 bookings is the most important near-term watch item. A sustained slowdown would challenge the growth thesis.
- Backlog quality and conversion: ATS’s backlog remains substantial, but investors should monitor whether revenue conversion supports margins and cash flow.
- Life sciences demand: This remains one of the strongest strategic verticals for ATS and a key support for the automation thesis.
- Tariff and capex uncertainty: Management noted that customer capital-expenditure timing can vary as customers evaluate tariffs and larger project decisions. ([businesswire.com](https://www.businesswire.com/news/home/20260528259819/en/ATS-Reports-Fourth-Quarter-Fiscal-2026-Results?utm_source=openai))
- Portfolio diversification: The next portfolio action should likely be adding a second high-quality automation name rather than exiting ATS prematurely.
Position decision
Decision: Hold ATS Corporation. Do not close.
There is no strong portfolio-management reason to close ATS. The position is newly initiated, remains within the protected minimum holding period, and continues to match the Smart Manufacturing Portfolio’s factory automation mandate. The recent order-booking softness deserves monitoring, but it is not enough to call the thesis broken. A temporary move in the share price, especially after only one day in the portfolio, should not drive the exit decision.
Bottom line
The Smart Manufacturing Portfolio is correctly anchored in ATS, a global automation company with direct exposure to advanced manufacturing needs. The portfolio is still under-diversified, so the next strategic priority is to broaden exposure across the automation value chain. For now, ATS remains a hold, and no positions should be closed this week.
Risk disclaimer: This portfolio review is for informational and editorial purposes only and is not financial advice. Stocks can decline in value, thematic investing can be volatile, and readers should conduct their own research or consult a qualified financial adviser before making investment decisions.